Judge Sets Deadline For Prempro MDL Discovery

Law360, New York (January 28, 2009, 12:00 AM EST) -- The judge presiding over a slew of cases alleging that Prempro and related hormone-replacement drugs cause breast cancer has ordered the plaintiffs to end their drawn-out discovery involving defendants Pfizer Inc. and Wyeth Pharmaceuticals Inc. by Sept. 1.

On Tuesday, in the U.S. District Court for the Eastern District of Arkansas, Judge William R. Wilson set the deadline for discovery involving defendants Pfizer and Wyeth, which markets Prempro, for which the multidistrict litigation over hormone treatments is named.

The judge agreed that some discovery should continue...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In Re: Prempro Products et al


Case Number

4:03-cv-01507

Court

Arkansas Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Billy Roy Wilson

Date Filed

March 7, 2003

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.